GMP Cell Therapy Consumables Market Size & Growth | 2028

report image

GMP Cell Therapy Consumables Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and  Research)

Publication Month: Nov 2022 | Report Code: TIPRE00029780 | No. of Pages: 220 | Category: Biotechnology | Status: Published

The GMP cell therapy consumables market is expected to grow from US$ 11,031.25 million in 2021 to US$ 59,985.89 million by 2028; it is estimated to grow at a CAGR of 27.5% from 2022 to 2028.

The GMP cell therapy consumables market is segmented on the basis of product, cell therapy, process, end use, and regions. The report offers insights and in-depth analysis of the market, emphasizing various parameters such as dynamics, trends, and opportunities of the market and competitive landscape analysis of leading market players across various regions. It also includes the impact analysis of COVID–19 pandemic across the regions.

Market Insights

Rise in Research & Development and Drug Discovery Drive Market Growth

Drug discovery is a long process that comprises various steps such as early discovery, preclinical phase, clinical phase, and regulatory approval. The process tremendously involves the use of cell therapy consumables to achieve the desired results. According to the World Health Organization, ~10 million deaths due to cancer were recorded in 2020, and the most common cancers are breast, lung, colon, rectum, and prostate cancers. Various research studies have shown positive outcomes of drugs that can effectively treat cancer, neurological disorders, autoimmune disorders, and other chronic disorders. Therefore, the rising prevalence of chronic disorders propels the demand for research and development (R&D) activities.

Moreover, numerous biotechnology companies operating in the market are collaborating with each other to accelerate R&D activities on a global level. For instance, in October 2022, Century Therapeutics and Bristol Myers Squibb announced the research collaboration and license agreement to develop and commercialize up to four induced pluripotent stem cells (“iPSC”) derived, engineered natural killer cell (“iNK”) and/or T cell (“iT”) programs for hematologic malignancies and solid tumors. Additionally, the rising demand for personalized and regenerative medicine has further boosted the growth of the cell therapy consumables market. An increase in drug discovery and R&D requires good manufacturing practices, and GMP consumables are required to obtain desired results from these activities. Thus, an increase in research & development activities, along with a surge in drug discovery, has increased the use of GMP cell therapy consumables.

GMP Cell Therapy Consumables Market - Strategic Insights

Report Coverage - GMP Cell Therapy Consumables Market
Report CoverageDetails
Market Size Value inUS$ 11,031.25 Million in 2021
Market Size Value byUS$ 59,985.89 Million by 2028
Growth rateCAGR of 27.5% from 2022 to 2028
Forecast Period2022-2028
Base Year2021
No. of Pages220
No. of Tables111
No. of Charts & Figures82
Historical data availableYes
Segments coveredProduct, Cell Therapy, Process, and End Use
Regional scopeNorth America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country scopeUS, Canada, Mexico, UK, Germany, Spain, Italy, France, India, China, Japan, South Korea, Australia, UAE, Saudi Arabia, South Africa, Brazil, Argentina
Report coverageRevenue forecast, company ranking, competitive landscape, growth factors, and trends
Free Sample Copy Available

Product-Based Insights

Based on product, the GMP cell therapy consumables market is segmented into kits, reagents/molecular biology reagents, growth factors/cytokines and interleukins, and others. In 2021, the kits segment held the largest market share. However, the growth factors/cytokines and interleukins segment are anticipated to register the highest CAGR in the market during 2022–2028. Reagents and supplements specifically designed for cell culture allow the growth and propagation of a wide spectrum of cell types under controlled conditions. TheraPEAK Products include an array of GMP buffers and reagents dedicated to the creation and development of cell and gene therapies. They are mainly produced in ISO: 13485 plants, such that these GMP solutions for cell and gene therapy are used by various customers in numerous clinical applications. There can be various types of molecular biology reagents that are GMP compliant in nature and mainly used in academics and clinical settings.

GMP Cell Therapy Consumables Market, by Product – 2021–2028

GMP Cell Therapy Consumables Market, by Product – 2021–2028

Get more information on this report :

Cell Therapy-Based Insights

Based on cell therapy, the GMP cell therapy consumables market is segmented into NK cell therapy, stem cell therapy, T-cell therapy, and others. In 2021, the T-cell therapy segment held the largest share of the market. However, the market in the NK cell therapy segment is expected to grow at the fastest rate during the forecast period. Chimeric antigen receptor (CAR) T-cell therapy is an immunotherapy used to treat certain types of cancer, especially blood cancer or leukemia. The therapy capitalizes the power of immune system protecting against the infections and illnesses by destroying harmful invaders, such as viruses and bacteria. Various research and clinical trials on CAR T-cell therapy are being conducted for cancer treatment. For instance, in January 2022, a new CAR T-cell therapy was developed by University College London (UCL) researchers. Phase-I clinical trials of this therapy carried out at UCL Hospitals (UCLH) concluded that this therapy has fewer toxic effects and is durable. Such increasing clinical trials of CAR T-cell therapy are surging the demand for GMP cell therapy consumables.

Process-Based Insights

Based on process, the GMP cell therapy consumables market is segmented into cell collection and characterization/sorting and separation, cell culture and expansion/preparation, cryopreservation, cell processing and formulation, cell isolation and activation, cell distribution/handling, process monitoring and control/readministration/quality assurance, and others. In 2021, the cell collection and characterization/sorting and separation segment held the largest share of the market. However, the GMP cell therapy consumables market in the cryopreservation segment is expected to grow at the fastest rate during the forecast period. Cell characterization is crucial for understanding the intrinsic factors involved in cellular proliferation, function, and overall process. Cells are sorted and separated based on these characteristics. Companies are building the GMP compliant cell sorter to avoid contamination during the process. For instance, Miltenyi Biotec sells MACSQuant Tyto Cell Sorter, a sterile and GMP compliant multiparametric cell sorting in a closed cartridge system. The company also provides a certificate of analysis (CoA), certificate of origin (CoO), and product information files (PIF) for the regulatory approval of cell manufacturing protocols.

End Use-Based Insights

Based on end use, the GMP cell therapy consumables market is segmented into clinical, commercial, and research. In 2021, the clinical segment held the largest share of the market. Also, the GMP cell therapy consumables market in the same segment is expected to grow at the fastest rate during the forecast period. In clinical use, cell therapy research is carried out on people to evaluate medical, surgical, or behavioral intervention of a particular therapy. Clinical trials are expanding due to the rising prevalence of chronic disorders, , increasing biologics, and rising number of contract research organizations undertaking clinical studies. Various cell therapies are expected to achieve market authorization in the coming years. According to a Nature article, 2,073 active cell therapy agents were in the pipeline in April 2021, which was 572 more than the 2020 update.

The GMP cell therapy consumables market players adopt organic strategies, such as product launch and expansion, to expand their footprint and product portfolio across the world and meet the growing demand. Inorganic growth strategies witnessed in the market are partnerships and collaborations. These growth strategies have allowed the market players to expand their businesses and enhance their geographic presence. Additionally, acquisitions, partnerships, and other growth strategies help strengthen the company’s customer base and increase its product portfolio.

  • In January 2021, Sartorius signed a strategic collaboration with RoosterBio Inc., a leading supplier of human mesenchymal stem/stromal cell (hMSC). The collaboration advanced the scale-up of hMSC manufacturing for regenerative medicine. RoosterBio and Sartorius created a set of GMP-compatible, customer-centric protocols using RoosterBio’s hMSC and media systems alongside Sartorius’s single-use manufacturing technologies, process control software, and cell analysis tools of hMSC final product manufacturing.
  • In September 2020, Bio-Techne Corporation opened an ~61,000 square foot state-of-the-art Good Manufacturing Practices (GMP) manufacturing facility. Located in St. Paul, MN, the new facility is dedicated to support large-scale production of GMP-grade materials, which are an essential component for many immuno-oncology and regenerative medicine cell and gene-modified therapy workflows. This facility helps the company meet current and future demand for the GMP-grade reagents that are necessary to support the rapidly growing cell therapy market.

GMP Cell Therapy Consumables Market - Company Profiles

  • Sartorius AG                             
  • Thermo Fisher Scientific Inc         
  • Miltenyi Biotec BV & Co KG          
  • Bio-Techne Corp                        
  • Corning Inc                               
  • FUJIFILM Irvine Scientific Inc        
  • Lonza Group AG                        
  • BPS Bioscience Inc                     
  • Merck KGaA                              
  • Global Life Sciences Solutions USA LLC.

Frequently Asked Questions

Good Manufacturing Practices (GMP) is a system for ensuring that products are consistently produced and controlled according to quality standards. Cell therapy manufacturing processes range in complexity. Cell therapy manufacturing processes require an underpinning pharmaceutical quality system and quality control (QC) laboratory, and all aspects of cell therapy manufacturing require trained personnel. As the process is complex there may be chances of contamination, therefore GMP in cell therapy is becoming mandatory. Also, the use of cell therapy for treatment of various diseases is increasing the demand for cell therapy consumables that are manufactured according to GMP regulations.
The factors driving the growth of GMP cell therapy consumables are Increase in research & development and drug discovery, as well as increase in strategic collaborations.
Stringent regulatory policies are expected to restrict the GMP cell therapy consumables growth during the forecast period.
The GMP cell therapy consumables majorly consist of the players, such as Sartorius AG, Thermo Fisher Scientific Inc, Miltenyi Biotec BV & Co KG, Bio-Techne Corp, Corning Inc, FUJIFILM Irvine Scientific Inc, Lonza Group AG, BPS Bioscience Inc, Merck KGaA, and Global Life Sciences Solutions USA LLC among others.
The global GMP cell therapy consumables based on the product are segmented into kits, reagents/molecular biology reagents, cell culture media and supplements, growth factors/cytokines and interleukins (including protein and nucleic acid purification buffers), and others. The kits segment held the largest market share in 2021. However, growth factors/cytokines and interleukins is anticipated to register the highest CAGR during the forecast period.
The global GMP cell therapy consumables based on regions is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. In 2021, the North American area held the largest market share. However, the Asia Pacific region is estimated to grow at the fastest CAGR of 29.6% during the forecast period

The List of Companies - GMP Cell Therapy Consumables Market

  1. Sartorius AG
  2. Thermo Fisher Scientific Inc
  3. Miltenyi Biotec BV & Co KG
  4. Bio-Techne Corp
  5. Corning Inc
  6. FUJIFILM Irvine Scientific Inc
  7. Lonza Group AG
  8. BPS Bioscience Inc
  9. Merck KGaA
  10. Global Life Sciences Solutions USA LLC
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the global GMP cell therapy consumables market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global GMP cell therapy consumables market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
TIPRE00029780
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market




Have a Question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Speak to Analyst
Pricing
  • $3000
  • $4550
  • $6550
  • $8550

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount